Boryung markets lung cancer diagnostic reagent MAZE kit

Published: 2004-07-22 06:57:00

Updated: 2004-07-22 06:57:00

Boryung Pharm said it has signed an agreement with Daeyong to distribute MAGE (melanoma antigen gene) kit, a patented lung cancer diagnostic reagent, to hospitals in Seoul and Kyunngi Province. The kit's test method was developed by Immune Cancer & Gene, a local biopharmaceutical firm.

The MAG...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK